Gilchuk Pavlo, Hill Timothy M, Wilson John T, Joyce Sebastian
Veterans Administration Tennessee Valley Healthcare System, Vanderbilt University, Nashville, TN 37332, USA; Department of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, TN 37332, USA.
Department of Pathology, Microbiology and Immunology, School of Medicine, Vanderbilt University, Nashville, TN 37332, USA.
Curr Opin Immunol. 2015 Jun;34:43-51. doi: 10.1016/j.coi.2015.01.013. Epub 2015 Feb 6.
Once a burgeoning field of study, over the past decade or so, T cell epitope discovery has lost some luster. The contributory factors perchance are the general notion that any newly discovered epitope will reveal very little about an immune response and that knowledge of epitopes are less critical for vaccine design. Despite these notions, the breadth and depth of T cell epitopes derived from clinically important microbial agents of human diseases largely remain ill defined. We review here a flurry of recent reports that have rebirthed the field. These reports reveal that epitope discovery is an essential step toward rational vaccine design and critical for monitoring vaccination efficacy. The new findings also indicate that neither immunogenicity nor immunodominance predict protective immunity. Hence, an immunogenic epitope is but a peptide unless proven protective against disease.
曾经是一个蓬勃发展的研究领域,在过去十年左右的时间里,T细胞表位发现已失去了一些光彩。促成这些因素的可能是一种普遍观念,即任何新发现的表位对免疫反应的揭示都很少,而且表位知识对疫苗设计的重要性较低。尽管有这些观念,但源自人类疾病临床重要微生物病原体的T细胞表位的广度和深度在很大程度上仍不明确。我们在此回顾一系列使该领域重获新生的近期报告。这些报告表明,表位发现是合理疫苗设计的关键步骤,对监测疫苗接种效果至关重要。新发现还表明,免疫原性和免疫显性都无法预测保护性免疫。因此,一个具有免疫原性的表位只不过是一个肽段,除非被证明对疾病具有保护作用。